1-3 of 3
Jesús San Miguel, MD
Close
Sort by
Journal Articles

Early Normalization of Serum Free Light Chain Is Associated with Prolonged Time to Progression Following Bortezomib ± Pegylated Liposomal Doxorubicin Treatment of Relapsed/Refractory Multiple Myeloma.

Robert Orlowski, MD, PhD, Heather Sutherland, MD, PhD, Joan Bladé, MD, Jesús San Miguel, MD, Roman Hájek, MD, PhD, Arnon Nagler, MD, MSc, Pieter Sonneveld, MD, PhD, Andrew Spencer, DM, Tadeusz Robak, MD, PhD, Suneel Mundle, PhD, Donghan Luo, PhD, Sen Hong Zhuang, MD, PhD, Jean-Luc Harousseau, MD
Journal: Blood
Blood (2007) 110 (11): 2735.
https://doi.org/10.1182/blood.V110.11.2735.2735
Published: 2007
Journal Articles

Anti-Thymocyte Globulin Induces Higher Response Rates and Less Graft-Versus-Host Disease in Multiple Myeloma Patients Undergoing Allogeneic Stem Cell Transplantation.

Francis Ayuk, MD, José A. Perez-Simon, MD, Avichai Shimoni, MD, Anna Sureda, MD, Tatjana Zabelina, MD, Rainer Schwerdtfeger, MD, Rodrigo Martino, MD, Herbert G. Sayer, MD, Adrián Alegre, MD, Juan-José Lahuerta, MD, Djordje Atanackovic, MD, Christine Wolschke, MD, Arnon Nagler, MD, Axel R. Zander, MD, Jesús San Miguel, MD, Nicolaus Kroeger, MD
Journal: Blood
Blood (2007) 110 (11): 2980.
https://doi.org/10.1182/blood.V110.11.2980.2980
Published: 2007
Journal Articles

Minimal Residual Disease (MRD) Evaluation by Flow Cytometry in Acute Leukemia Patients Undergoing Allogeneic Stem Cell Transplantation.

Maria-Belen Vidriales, MD, PhD, Jose J. Pérez, Consuelo López-Berges, MD, PhD, Norma C. Gutierrez, MD, PhD, Juana Ciudad, PhD, Lourdes Vazquez, MD, PhD, Consuelo del Cañizo, MD, PhD, Joaquín Díaz-Mediavilla, MD, PhD, Javier Fernández-Calvo, MD, Fernando Ramos, MD, PhD, María Jesús Rodriguez, MD, PhD, María José Calmuntia, MD, PhD, Alberto Orfao, MD, PhD, Jesús San Miguel, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 1103.
https://doi.org/10.1182/blood.V104.11.1103.1103
Published: 2004